P3 Health Partners Q3 2026 adjusted EBITDA swings to positive $20.87 million
PIII•P3 Health Partners reported third-quarter 2026 adjusted EBITDA of $20.87 million, compared with a year-earlier loss of $45.91 million. It raised FY26 adjusted EBITDA guidance to $90 million–$110 million and said at-risk membership fell 9% year over year to approximately 105,000.
1. Quarterly results and outlook
P3 Health Partners swung to third-quarter 2026 adjusted EBITDA of $20.87 million from a loss of $45.91 million a year earlier. The company raised FY26 adjusted EBITDA guidance to $90 million–$110 million, with a midpoint of $100 million. At-risk membership fell 9% year over year to approximately 105,000, reflecting intentional network and payer rationalization.
